AU2023257557A1 - Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate - Google Patents
Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate Download PDFInfo
- Publication number
- AU2023257557A1 AU2023257557A1 AU2023257557A AU2023257557A AU2023257557A1 AU 2023257557 A1 AU2023257557 A1 AU 2023257557A1 AU 2023257557 A AU2023257557 A AU 2023257557A AU 2023257557 A AU2023257557 A AU 2023257557A AU 2023257557 A1 AU2023257557 A1 AU 2023257557A1
- Authority
- AU
- Australia
- Prior art keywords
- iminosugars
- accumulation
- mondnj
- treatment
- nbdnj
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102022000007808A IT202200007808A1 (it) | 2022-04-20 | 2022-04-20 | Composizioni terapeutiche per malattie causate da accumulo di eparan solfato |
| IT102022000007808 | 2022-04-20 | ||
| PCT/EP2023/059966 WO2023203004A1 (en) | 2022-04-20 | 2023-04-18 | Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023257557A1 true AU2023257557A1 (en) | 2024-12-05 |
Family
ID=82483266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023257557A Pending AU2023257557A1 (en) | 2022-04-20 | 2023-04-18 | Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250255856A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4511032A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025513384A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119136803A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023257557A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3249619A1 (cg-RX-API-DMAC7.html) |
| IT (1) | IT202200007808A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024012934A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023203004A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2083205C1 (ru) | 1994-01-19 | 1997-07-10 | Товарищество с ограниченной ответственностью предприятие "БИОМ" | Способ лечения мукополисахаридоза |
| RU2196988C2 (ru) | 2000-04-19 | 2003-01-20 | Государственный новосибирский областной клинический диагностический центр | Способ диагностики мукополисахаридозов |
| US20040204379A1 (en) * | 2000-06-19 | 2004-10-14 | Cheng Seng H. | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| AU2002241853A1 (en) | 2001-01-12 | 2002-07-24 | Oxford Glycosciences (Uk) Ltd. | Mucopolysaccharidosis therapies |
| JP2003265196A (ja) | 2002-03-15 | 2003-09-24 | Seikagaku Kogyo Co Ltd | ムコ多糖症のスクリーニング方法 |
| AUPS293002A0 (en) | 2002-06-14 | 2002-07-04 | Women's And Children's Hospital | Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders |
| KR100762945B1 (ko) | 2004-09-08 | 2007-10-04 | 진동규 | 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주 |
| PL377180A1 (pl) | 2005-09-21 | 2007-04-02 | Instytut Farmaceutyczny | Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz |
| US8105788B2 (en) | 2005-12-08 | 2012-01-31 | The University Of British Columbia | Mucopolysaccharidosis (MPS) diagnostic methods, systems, kits and assays associated therewith |
| US20070161074A1 (en) | 2005-12-27 | 2007-07-12 | Daiichi Pharmaceutical Co., Ltd. | Diagnostic method of mucopolysaccharidoses |
| EP2473482B1 (en) * | 2009-09-04 | 2014-03-05 | United Therapeutics Corporation | Methods of treating orthomyxoviral infections |
| US9206401B2 (en) | 2010-12-22 | 2015-12-08 | Fondazione Telethon | Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses |
| ES2664844T3 (es) | 2011-06-20 | 2018-04-23 | Mount Sinai School Of Medicine | Tratamiento dirigido contra TNF para las mucopolisacaridosis y otros trastornos lisosómicos |
| CN106102464A (zh) * | 2013-05-02 | 2016-11-09 | 牛津大学之校长及学者 | 采用亚氨基糖的糖脂抑制 |
| WO2017201030A1 (en) * | 2016-05-16 | 2017-11-23 | Emergent Virology Llc | Methods of treating viral infection |
-
2022
- 2022-04-20 IT IT102022000007808A patent/IT202200007808A1/it unknown
-
2023
- 2023-04-18 JP JP2024561909A patent/JP2025513384A/ja active Pending
- 2023-04-18 CN CN202380034938.2A patent/CN119136803A/zh active Pending
- 2023-04-18 WO PCT/EP2023/059966 patent/WO2023203004A1/en not_active Ceased
- 2023-04-18 CA CA3249619A patent/CA3249619A1/en active Pending
- 2023-04-18 US US18/856,892 patent/US20250255856A1/en active Pending
- 2023-04-18 AU AU2023257557A patent/AU2023257557A1/en active Pending
- 2023-04-18 EP EP23720571.1A patent/EP4511032A1/en active Pending
-
2024
- 2024-10-18 MX MX2024012934A patent/MX2024012934A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023203004A1 (en) | 2023-10-26 |
| IT202200007808A1 (it) | 2023-10-20 |
| JP2025513384A (ja) | 2025-04-24 |
| CN119136803A (zh) | 2024-12-13 |
| MX2024012934A (es) | 2024-12-06 |
| CA3249619A1 (en) | 2023-10-26 |
| US20250255856A1 (en) | 2025-08-14 |
| EP4511032A1 (en) | 2025-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230321130A1 (en) | Senolytic Compositions and Uses Thereof | |
| JP2007502861A (ja) | 抗菌方法及び組成物 | |
| D’Alonzo et al. | N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe Disease | |
| JP2020037578A (ja) | プロテオパチーの処置のためのベンジリデングアニジン誘導体の新規な治療的使用 | |
| De Pasquale et al. | N-substituted l-Iminosugars for the treatment of Sanfilippo type B syndrome | |
| EP4074696A1 (en) | Compound as potassium channel regulator, and preparation and use thereof | |
| AU2021269232B2 (en) | Non-lysosomal glucosylceramidase inhibitors and uses thereof | |
| US8178609B2 (en) | Isoflavones for treating mucopolysaccharidoses | |
| WO2023203004A1 (en) | Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate | |
| JP2022502486A (ja) | 細菌感染の処置における使用のためのインダン誘導体 | |
| US20220227802A1 (en) | Antibacterial aminoglycoside derivatives | |
| AU2019217292B2 (en) | Novel compound for preventing or treating neurodegenerative disease and application thereof | |
| EP3126333B1 (en) | Pqsr modulators | |
| WO2012048417A1 (en) | Inhibitors of p75 receptor and their uses | |
| WO2021142312A1 (en) | Methods and compositions related to heparinoids | |
| RU2791317C2 (ru) | Новая композиция для предупреждения или лечения нейродегенеративного расстройства и ее применение | |
| Esposito | Synthesis and biological evaluation of novel therapeutic candidates for the treatment of infectious and rare diseases | |
| US10537545B2 (en) | Ceramide derivatives as anticancer agents | |
| KR101881115B1 (ko) | 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도 | |
| EA045519B1 (ru) | Антибактериальные производные аминогликозидов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: SWELL THERAPEUTICS LLC Free format text: FORMER APPLICANT(S): PAVONE, LUIGI MICHELE; GUARAGNA, ANNALISA; DE PASQUALE, VALERIA; ESPOSITO, ANNA; D'AGOSTINO, MASSIMO |